MAZZANTI, ROBERTO

MAZZANTI, ROBERTO  

Medicina Sperimentale e Clinica  

Mostra records
Risultati 1 - 20 di 114 (tempo di esecuzione: 0.094 secondi).
Titolo Data di pubblicazione Autore(i) File
Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues 2013 Fan Lin; Serena Marchetti; Dick Pluim; Dilek Iusuf; Roberto Mazzanti; Jan H.M. Schellens; Jos H. Beijnen; Olaf van Tellingen
Action of acute ethanol intake on rat biliary secretion: effect of epomediol. 1986 Chiarantini E; Mazzanti R; Buzzelli G; Chieca R; Coletta D; Orlandini F; Romeo D; Arena U.
Acute and chronic exposure to ethanol and the electrophysiology of the brush border membrane of rat small intestine. 1989 al-Balool F; Debnam ES; Mazzanti R.
Acute pyhase proteins in alcoholics with or without liver injury 1992 G.Lippi; S.Fedi; M.Grassi; E.Rosi. AA.Liotta; A.Fontanelli; AP.Cellai; R.Mazzanti
Alcoholic hepatopathy in Tuscany. Preliminary results of a multicenter study 1987 Gentilini P; Mazzanti R; Buzzelli G; Baronti E; Gialdini D; Romeo D; Palieri A.
"Alkaline" components of gastro-esophageal reflux are not completely precipitated by acid gastric environment. 1998 Bechi P; Mazzanti R; Fiorillo C; Fantappiè O; Cianchi F; Lunghi B; Pacini A; Nassi P
Althesin (steroid intravenous anesthetic) and microsomal enzymes 1974 Lorenzi P; Marsili M; Mazzanti R.
An insight into post-gastrectomy "alkaline reflux gastritis". 1986 Bechi P; Carcangiu ML; Mazzanti R; Pacini F; Tonelli P; Gregorini M; Arcangeli G; Borsotti M; Tonelli L.
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report 2005 C. FULIGNATI; P. PANTALEO; G. CIPRIANI; M. TURRINI; R. NICASTRO; R. MAZZANTI; B. NERI
Benzquinamide inhibits p-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells. 1992 R. MAZZANTI; J.M. CROOP; Z. GATMAITAN; M. BUDDING; K. STEIGLITZ; R. ARCECI; I.M ARIAS
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles 1994 R. MAZZANTI; O. FANTAPPIE'; Y. KAMIMOTO; Z. GATMAITAN; P. GENTILINI; I.M. ARIAS
Billroth I versus Billroth II partial gastrectomy in the treatment of gastric ulcer 1988 Bechi P; Naspetti R; Mazzanti R; Castiglione G; Tonelli P; Amorosi A; Tonelli L.
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 2009 Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L
Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases? 1986 Mazzanti R; Chiarantini E; Baronti E; Moscarella S; Arena U; Buzzelli G.
Characteristics of hepatocellular carcinoma in Italy. 1998 T. STROFFOLINI; P NDREONE; A. ANDRIULLI; R. MAZZANTI; ET AL.
Chemotherapy of primary and secondary liver cancer: is it useful? 1986 Buzzelli G; Smorlesi C; Mazzanti R; Pampana A; Matassi L; Simondi P; Gentilini P.
Chronic liver diseases with normal blood protein levels] 1977 Buzzelli G; Gallerini L; Guarducci AM; Laffi G; Mazzanti R; Smorlesi C; Gentilini P.
Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis 1997 MAZZANTI R; MESSERINI L; MONSACCHI L; BUZZELLI G; A. ZIGNEGO; FOSCHI M; MONTI M; LAFFI G; MORBIDELLI L; FANTAPPIE' O; BARTOLONI SAINT OMER F; ZICHE M.
Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. 1997 Mazzanti R;Messerini L;Monsacchi L;Buzzelli G;Zignego AL;Foschi M;Monti M;Laffi G;Morbidelli L;Fantappié O;Bartoloni Saint Omer F;Ziche M
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 1996 P. Gentilini; G. Laffi; G. La Villa; V. Casini-Raggi; R.G. Romanelli; G Buzzelli; R. Mazzanti; F. Marra; M. Pinzani; A.L. Zignego.